Hotgen(SH:688068) Zheng Quan Zhi Xing·2025-07-04 16:34Core Viewpoint - The legal opinion letter confirms that the procedures for convening and holding the third extraordinary general meeting of shareholders of Beijing Hotgen Biotech Co., Ltd. are in compliance with relevant laws and regulations, and the resolutions passed during the meeting are valid and effective [1][15]. Group 1: Meeting Procedures - The meeting was convened by the company's board of directors, with a notice issued 15 days prior to the meeting date [2][3]. - The meeting took place on July 4, 2025, at a specified location, combining both on-site and online voting methods [4][5]. - The meeting's time, location, and agenda were consistent with the announced details [4][5]. Group 2: Attendance and Voting - A total of 85,972,334 shares were eligible for voting, with 24,093,844 shares represented at the on-site meeting, accounting for 28.0251% of the total voting shares [5]. - Online voting involved 214 shareholders, representing 32,471,796 shares, which is 37.7701% of the total voting shares [5]. - The qualifications of all attendees were verified as legitimate and valid [5]. Group 3: Resolutions Passed - The meeting reviewed several resolutions, including the election of the fourth board of directors and amendments to governance policies [7][8]. - The resolutions received overwhelming support, with the election of non-independent directors receiving 99.9571% approval [8][10]. - The resolutions were deemed to comply with the requirements of the Company Law and the company's articles of association [7][15].